20. Wilson MS, Madala SK, Ramalingam TR, Gochuico BR, Rosas IO, et al. (2010) Bleomycin and IL-1beta-mediated pulmonary fibrosis is IL-17A de- pendent. The Journal of experimental medicine 207: 535–552. 21. Jones MR, Simms BT, Lupa MM, Kogan MS, Mizgerd JP (2005) Lung NF- kappaB activation and neutrophil recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia. Journal of immunology 175: 7530– 7535. 22. Schultz MJ, Rijneveld AW, Florquin S, Edwards CK, Dinarello CA, et al. (2002) Role of interleukin-1 in the pulmonary immune response during Pseudomonas aeruginosa pneumonia. American journal of physiology Lung cellular and molecular physiology 282: L285–290. 23. Zwijnenburg PJ, van der Poll T, Florquin S, Roord JJ, Van Furth AM (2003) IL- 1 receptor type 1 gene-deficient mice demonstrate an impaired host defense against pneumococcal meningitis. Journal of immunology 170: 4724–4730. 24. Schmitz N, Kurrer M, Bachmann MF, Kopf M (2005) Interleukin-1 is responsible for acute lung immunopathology but increases survival of respiratory influenza virus infection. Journal of virology 79: 6441–6448. 25. Ichinohe T, Lee HK, Ogura Y, Flavell R, Iwasaki A (2009) Inflammasome recognition of influenza virus is essential for adaptive immune responses. The Journal of experimental medicine 206: 79–87. 26. Perrone LA, Szretter KJ, Katz JM, Mizgerd JP, Tumpey TM (2010) Mice lacking both TNF and IL-1 receptors exhibit reduced lung inflammation and delay in onset of death following infection with a highly virulent H5N1 virus. The Journal of infectious diseases 202: 1161–1170. 27. Smith DE, Renshaw BR, Ketchem RR, Kubin M, Garka KE, et al. (2000) Four new members expand the interleukin-1 superfamily. J Biol Chem 275: 1169– 1175. 28. Kumar S, McDonnell PC, Lehr R, Tierney L, Tzimas MN, et al. (2000) Identification and initial characterization of four novel members of the interleukin-1 family. J Biol Chem 275: 10308–10314. 29. Nicklin MJ, Barton JL, Nguyen M, FitzGerald MG, Duff GW, et al. (2002) A sequence-based map of the nine genes of the human interleukin-1 cluster. Genomics 79: 718–725. 30. Debets R, Timans JC, Homey B, Zurawski S, Sana TR, et al. (2001) Two novel IL-1 family members, IL-1 delta and IL-1 epsilon, function as an antagonist and agonist of NF-kappa B activation through the orphan IL-1 receptor-related protein 2. J Immunol 167: 1440–1446. 31. Towne JE, Garka KE, Renshaw BR, Virca GD, Sims JE (2004) Interleukin (IL)- 1F6, IL-1F8, and IL-1F9 signal through IL-1Rrp2 and IL-1RAcP to activate the pathway leading to NF-kappaB and MAPKs. J Biol Chem 279: 13677–13688. 32. Dinarello C, Arend W, Sims J, Smith D, Blumberg H, et al. (2010) IL-1 family nomenclature. Nat Immunol 11: 973. 33. Barksby HE, Lea SR, Preshaw PM, Taylor JJ (2007) The expanding family of interleukin-1 cytokines and their role in destructive inflammatory disorders. Clin Exp Immunol 149: 217–225. 34. van de Veerdonk FL, Stoeckman AK, Wu G, Boeckermann AN, Azam T, et al. (2012) IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proceedings of the National Academy of Sciences of the United States of America 109: 3001–3005. 35. Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27: 519–550. 36. Dinarello CA (1996) Biologic basis for interleukin-1 in disease. Blood 87: 2095– 2147. 37. Ramadas RA, Li X, Shubitowski DM, Samineni S, Wills-Karp M, et al. (2006) IL-1 Receptor antagonist as a positional candidate gene in a murine model of allergic asthma. Immunogenetics 58: 851–855. 38. Ramadas RA, Ewart SL, Medoff BD, LeVine AM (2011) Interleukin-1 family member 9 stimulates chemokine production and neutrophil influx in mouse lungs. Am J Respir Cell Mol Biol 44: 134–145. 39. Chustz RT, Nagarkar DR, Poposki JA, Favoreto S, Jr., Avila PC, et al. (2011) Regulation and Function of the IL-1 Family Cytokine IL-1F9 in Human Bronchial Epithelial Cells. Am J Respir Cell Mol Biol 45: 145–153. 40. Vos JB, van Sterkenburg MA, Rabe KF, Schalkwijk J, Hiemstra PS, et al. (2005) Transcriptional response of bronchial epithelial cells to Pseudomonas aerugi- nosa: identification of early mediators of host defense. Physiol Genomics 21: 324–336. 41. DeVoti JA, Rosenthal DW, Wu R, Abramson AL, Steinberg BM, et al. (2008) Immune dysregulation and tumor-associated gene changes in recurrent respiratory papillomatosis: a paired microarray analysis. Mol Med 14: 608–617. 42. Blumberg H, Dinh H, Dean C, Jr., Trueblood ES, Bailey K, et al. (2010) IL- 1RL2 and its ligands contribute to the cytokine network in psoriasis. J Immunol 185: 4354–4362. 43. Blumberg H, Dinh H, Trueblood ES, Pretorius J, Kugler D, et al. (2007) Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation. J Exp Med 204: 2603–2614. 44. Johnston A, Xing X, Guzman AM, Riblett M, Loyd CM, et al. (2010) IL-1F5, - F6, -F8, and -F9: a novel IL-1 family signaling system that is active in psoriasis and promotes keratinocyte antimicrobial peptide expression. J Immunol 186: 2613–2622. 45. Carrier Y, Ma HL, Ramon HE, Napierata L, Small C, et al. (2011) Inter- regulation of Th17 cytokines and the IL-36 cytokines in vitro and in vivo: implications in psoriasis pathogenesis. The Journal of investigative dermatology 131: 2428–2437. IL-36a and Pulmonary Inflammation 46. Marrakchi S, Guigue P, Renshaw BR, Puel A, Pei XY, et al. (2011) Interleukin- 36-receptor antagonist deficiency and generalized pustular psoriasis. The New England journal of medicine 365: 620–628. 47. Horai R, Asano M, Sudo K, Kanuka H, Suzuki M, et al. (1998) Production of mice deficient in genes for interleukin (IL)-1alpha, IL-1beta, IL-1alpha/beta, and IL-1 receptor antagonist shows that IL-1beta is crucial in turpentine- induced fever development and glucocorticoid secretion. J Exp Med 187: 1463– 1475. 48. Stacey KJ, Young GR, Clark F, Sester DP, Roberts TL, et al. (2003) The molecular basis for the lack of immunostimulatory activity of vertebrate DNA. Journal of immunology 170: 3614–3620. 49. Poltorak A, He X, Smirnova I, Liu MY, Van Huffel C, et al. (1998) Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. Science 282: 2085–2088. 50. Jeyaseelan S, Chu HW, Young SK, Freeman MW, Worthen GS (2005) Distinct roles of pattern recognition receptors CD14 and Toll-like receptor 4 in acute lung injury. Infection and immunity 73: 1754–1763. 51. Vigne S, Palmer G, Lamacchia C, Martin P, Talabot-Ayer D, et al. (2011) IL- 36R ligands are potent regulators of dendritic and T cells. Blood. 52. Lappalainen U, Whitsett JA, Wert SE, Tichelaar JW, Bry K (2005) Interleukin- 1beta causes pulmonary inflammation, emphysema, and airway remodeling in the adult murine lung. Am J Respir Cell Mol Biol 32: 311–318. 53. Leff JA, Baer JW, Bodman ME, Kirkman JM, Shanley PF, et al. (1994) Interleukin-1-induced lung neutrophil accumulation and oxygen metabolite- mediated lung leak in rats. Am J Physiol 266: L2–8. 54. Calkins CM, Bensard DD, Shames BD, Pulido EJ, Abraham E, et al. (2002) IL-1 regulates in vivo C-X-C chemokine induction and neutrophil sequestration following endotoxemia. Journal of endotoxin research 8: 59–67. 55. Ulich TR, Yin SM, Guo KZ, del Castillo J, Eisenberg SP, et al. (1991) The intratracheal administration of endotoxin and cytokines. III. The interleukin-1 (IL-1) receptor antagonist inhibits endotoxin- and IL-1-induced acute in- flammation. The American journal of pathology 138: 521–524. 56. Heiman AS, Abonyo BO, Darling-Reed SF, Alexander MS (2005) Cytokine- stimulated human lung alveolar epithelial cells release eotaxin-2 (CCL24) and eotaxin-3 (CCL26). J Interferon Cytokine Res 25: 82–91. 57. Jedrzkiewicz S, Nakamura H, Silverman ES, Luster AD, Mansharamani N, et al. (2000) IL-1beta induces eotaxin gene transcription in A549 airway epithelial cells through NF-kappaB. Am J Physiol Lung Cell Mol Physiol 279: L1058– 1065. 58. Manzer R, Wang J, Nishina K, McConville G, Mason RJ (2006) Alveolar epithelial cells secrete chemokines in response to IL-1beta and lipopolysaccha- ride but not to ozone. Am J Respir Cell Mol Biol 34: 158–166. 59. Bry K, Whitsett JA, Lappalainen U (2007) IL-1beta disrupts postnatal lung morphogenesis in the mouse. Am J Respir Cell Mol Biol 36: 32–42. 60. Afshar R, Medoff BD, Luster AD (2008) Allergic asthma: a tale of many T cells. Clin Exp Allergy 38: 1847–1857. 61. Lenschow DJ, Walunas TL, Bluestone JA (1996) CD28/B7 system of T cell costimulation. Annual review of immunology 14: 233–258. 62. Ben-Sasson SZ, Hu-Li J, Quiel J, Cauchetaux S, Ratner M, et al. (2009) IL-1 acts directly on CD4 T cells to enhance their antigen-driven expansion and differentiation. Proceedings of the National Academy of Sciences of the United States of America 106: 7119–7124. 63. McLellan AD, Sorg RV, Williams LA, Hart DN (1996) Human dendritic cells activate T lymphocytes via a CD40: CD40 ligand-dependent pathway. European journal of immunology 26: 1204–1210. 64. Howland KC, Ausubel LJ, London CA, Abbas AK (2000) The roles of CD28 and CD40 ligand in T cell activation and tolerance. Journal of immunology 164: 4465–4470. 65. Kugathasan K, Roediger EK, Small CL, McCormick S, Yang P, et al. (2008) CD11c+ antigen presenting cells from the alveolar space, lung parenchyma and spleen differ in their phenotype and capabilities to activate naive and antigen- primed T cells. BMC immunology 9: 48. 66. Choi IW, Kim DK, Ko HM, Lee HK (2004) Administration of antisense phosphorothioate oligonucleotide to the p65 subunit of NF-kappaB inhibits established asthmatic reaction in mice. Int Immunopharmacol 4: 1817–1828. 67. Desmet C, Gosset P, Pajak B, Cataldo D, Bentires-Alj M, et al. (2004) Selective blockade of NF-kappa B activity in airway immune cells inhibits the effector phase of experimental asthma. J Immunol 173: 5766–5775. 68. Poynter ME, Cloots R, van Woerkom T, Butnor KJ, Vacek P, et al. (2004) NF- kappa B activation in airways modulates allergic inflammation but not hyperresponsiveness. J Immunol 173: 7003–7009. 69. Towne JE, Renshaw BR, Douangpanya J, Lipsky BP, Shen M, et al. (2011) Interleukin-36 (IL-36) ligands require processing for full agonist (IL-36alpha, IL- 36beta, and IL-36gamma) or antagonist (IL-36Ra) activity. The Journal of biological chemistry 286: 42594–42602. 70. Sims JE, Smith DE (2010) The IL-1 family: regulators of immunity. Nature reviews Immunology 10: 89–102. 71. MacKenzie A, Wilson HL, Kiss-Toth E, Dower SK, North RA, et al. (2001) Rapid secretion of interleukin-1beta by microvesicle shedding. Immunity 15: 825–835. 72. Hamon Y, Luciani MF, Becq F, Verrier B, Rubartelli A, et al. (1997) Interleukin-1beta secretion is impaired by inhibitors of the Atp binding cassette transporter, ABC1. Blood 90: 2911–2915. PLOS ONE | www.plosone.org 16 September 2012 | Volume 7 | Issue 9 | e45784